Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orathecin granted European orphan medical product status for pancreatic cancer

June 13, 2003

Genasense enters new combination trial in advanced breast cancer

June 13, 2003

Rutgers scientists identify novel topoisomerase inhibitors for cancer and other uses

June 13, 2003

Reduced tumorigenicity of prostate cancer cells found with contortrostatin

June 13, 2003

Evidence of response found with 2-methoxyestradiol in solid tumors

June 13, 2003

Good safety profile suggested for the antiangiogenic PI-88 in advanced solid cancer

June 13, 2003

Celecoxib with chemotherapy reported safe as palliative therapy for relapsed NHL

June 13, 2003

CT-2106 to advance into phase II trials

June 12, 2003

Phase I/II trial to study CA4P plus chemotherapy in advanced ovarian cancer

June 12, 2003

TheraCIM produces complete responses in head and neck cancer

June 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...